Presentation is loading. Please wait.

Presentation is loading. Please wait.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Published byMyron Baker Modified over 5 years ago

Similar presentations

Presentation on theme: "Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology."— Presentation transcript:

1 Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 40, Issue 17, 28 December 2018, Pages 1342–1351, The content of this slide may be subject to copyright: please see the slide notes for details.

2 Figure 1 Echocardiographic still frames of patients with degenerative and rheumatic mitral stenosis. Rheumatic mitral ... Figure 1 Echocardiographic still frames of patients with degenerative and rheumatic mitral stenosis. Rheumatic mitral stenosis is characterized by commissural fusion, chordal shortening and fusion, and leaflet thickening or restricted leaflet motion due to extensive calcification (A–D). Degenerative mitral stenosis is characterized by annular calcification in combination with leaflet thickening and/or calcification, and restriction of leaflet motion without commissural fusion (E–H). Blue arrows indicate commissural fusion. Red arrows indicate leaflet thickening due to extensive calcification. Orange arrows indicate mitral annular calcification. Yellow arrows indicate absence of commissural fusion. Green arrows indicate annular calcification in combination with leaflet calcification. Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 40, Issue 17, 28 December 2018, Pages 1342–1351, The content of this slide may be subject to copyright: please see the slide notes for details.

3 Figure 2 A flowchart of patients included in the present analysis.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 40, Issue 17, 28 December 2018, Pages 1342–1351, The content of this slide may be subject to copyright: please see the slide notes for details.

4 Figure 3 The Kaplan–Meier curve of (A) cardiovascular death and (B) disabling stroke for patients with concomitant ... Figure 3 The Kaplan–Meier curve of (A) cardiovascular death and (B) disabling stroke for patients with concomitant mitral stenosis (blue) and without mitral stenosis (red). Landmark analysis at 30 days of (C) cardiovascular death and (D) disabling stroke for patients with concomitant mitral stenosis (blue) and without mitral stenosis (red). Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 40, Issue 17, 28 December 2018, Pages 1342–1351, The content of this slide may be subject to copyright: please see the slide notes for details.

5 Figure 4 Bar graph illustrating disabling stroke and cardiovascular death in (A) patients with no, mild, and ... Figure 4 Bar graph illustrating disabling stroke and cardiovascular death in (A) patients with no, mild, and moderate/severe mitral stenosis and (B) patients with no, degenerative, and rheumatic mitral stenosis at 1 year. <sup>a</sup>Adjusted hazard ratios (95% confidence intervals). Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 40, Issue 17, 28 December 2018, Pages 1342–1351, The content of this slide may be subject to copyright: please see the slide notes for details.

6 Take home figure The Kaplan–Meier curve of cardiovascular death.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) For permissions, please article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model ( Eur Heart J, Volume 40, Issue 17, 28 December 2018, Pages 1342–1351, The content of this slide may be subject to copyright: please see the slide notes for details.

Download ppt "Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology."

Similar presentations

Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.

Figure 1 Rates of complications and mortality during index admission for atrial fibrillation ablation for the overall ... Figure 1 Rates of complications.
Figure 1 Subject phenotypes and most common genotype in subjects enrolled in THAOS in continental Western Europe. Data ... Figure 1 Subject phenotypes.

Figure 1 Subject phenotypes and most common genotype in subjects enrolled in THAOS in continental Western Europe. Data ... Figure 1 Subject phenotypes.
Figure 1 Overall lag-cumulative exposure–response relationships between air temperature and myocardial infarction ... Figure 1 Overall lag-cumulative exposure–response.

Figure 1 Overall lag-cumulative exposure–response relationships between air temperature and myocardial infarction ... Figure 1 Overall lag-cumulative exposure–response.
Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.

Unless provided in the caption above, the following copyright applies to the content of this slide: © 2019 European Society of Cardiology and British Pharmacological.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 Flowchart of our CIS cohort considering patients (A) and eyes (B) as statistical unit. Unless provided in the caption above, the following copyright.

Figure 1 Flowchart of our CIS cohort considering patients (A) and eyes (B) as statistical unit. Unless provided in the caption above, the following copyright.
Figure 1 Data-selection process

Figure 1 Data-selection process
Figure 1 Flow diagram detailing the systematic review process.

Figure 1 Flow diagram detailing the systematic review process.
Figure 1 Multivariable-adjusted predictors of PAC

Figure 1 Multivariable-adjusted predictors of PAC
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.

Figure 1 Unadjusted Kaplan–Meier curves for all-cause mortality in the transcatheter mitral valve repair and ... Figure 1 Unadjusted Kaplan–Meier curves.
Figure 1 Mechanism of mortality benefit associated with radial access

Figure 1 Mechanism of mortality benefit associated with radial access
Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published on behalf of the European Society of Cardiology.
Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.

Figure 1 Number of percutaneous coronary interventions (PCI) in mainland China, 2017 (total 753 142). Data from China ... Figure 1 Number of percutaneous.
Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.

Fig. 1. Relative potency ratios of 13 active ingredients used against a fall armyworm population collected in Puerto ... Fig. 1. Relative potency ratios.
Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.

Unless provided in the caption above, the following copyright applies to the content of this slide: Published by Oxford University Press on behalf of the.
Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.

Figure 1 The Kaplan–Meier curves of time to death post first hospitalization. hosp, hospitalization. Unless provided in the caption above, the following.
AHA: American Heart Association; ALT: ...

AHA: American Heart Association; ALT: ...
Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Figure 1. Serum ceftazidime concentrations following intravenous administration. Unless provided in the caption above, the following copyright applies.

Similar presentations

Ads by Google